// App-Quantinova.ai

4595 : Development and validation of a novel EGF receptor-neutralizing monoclonal antibody

Researchers

Presenter

  • Krystyna Zuberek Hincman

Principal Investigators

  • Christopher A. Manning

  • Michael R. Nelson

  • Michael Lewis

  • Roy Scialdone

  • Jaime Darce

  • Stephen R. Lutz

  • Evans Burford

  • Herbert Haack

  • Matthew R. Silver

Medical Centers

  • Cell Signaling Technology, Danvers, MA.

Locations

  • United States

Companies

  • Cell Signaling Techn

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • panitumumab

  • Erbitux

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved